Semaglutide peptides have arisen as a intriguing treatment in recent years, primarily for managing a 2 diabetes. Similar drugs operate by copying the body's own GLP-1 messenger, helping in regulate sugar content and encourage fat management. Although initially developed for diabetic individuals, its potential for obesity have currently being invest